Announcements Trials
Browse Landscape

Phase

Phase 4 3

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Esophageal Neoplasms 3Chemoradiotherapy 1

Interventions

Cisplatin 109Radiotherapy 100Fluorouracil 90Paclitaxel 75Oxaliplatin 63Docetaxel 56Carboplatin 55Irinotecan 41Esophagectomy 41Leucovorin 40Capecitabine 39Surgical Procedures, Operative 36Radiation 36Drug Therapy 31Neoadjuvant Therapy 25Chemoradiotherapy 18Cetuximab 18S 1 (combination) 17pembrolizumab 16camrelizumab 16Nivolumab 15Magnetic Resonance Spectroscopy 15Bevacizumab 15Blood Specimen Collection 14Surveys and Questionnaires 12Radiotherapy, Intensity-Modulated 12Immunotherapy 11Epirubicin 11Biopsy 11Trastuzumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Esophageal Neoplasms × sodium glycididazole × Clear all
NCT02721550 2019-10-11

A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC

Shandong Cancer Hospital and Institute

Phase 4 Terminated
2 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02721563 2019-10-11

A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

Shandong Cancer Hospital and Institute

Phase 4 Completed
77 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02721576 2019-10-11

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

Shandong Cancer Hospital and Institute

Phase 4 Terminated
8 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡